The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.
Study Type
OBSERVATIONAL
Enrollment
4,188
This was an observational study. Therefore, the physician decided about dosage according to individual needs (20 or 40 mg pantoprazole).
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Heartburn
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Eructation/Sour Eructation
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Painful Swallowing
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Reflux Symptoms
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Time frame: 14 days
Functional Dyspepsia Symptoms: Assessment of the Severity of Upper Abdominal Pain
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Functional Dyspepsia Symptoms: Assessment of the Severity of Sensation of Fullness
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Functional Dyspepsia Symptoms: Assessment of the Severity of Nausea
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Nycomed Deutschland GmbH
Aachen, Germany
Nycomed Deutschland GmbH
Aachen, Germany
Nycomed Deutschland GmbH
Ahrensburg, Germany
Nycomed Deutschland GmbH
Alpenrod, Germany
Nycomed Deutschland GmbH
Altenburg, Germany
Nycomed Deutschland GmbH
Altenholz, Germany
Nycomed Deutschland GmbH
Altenkirchen, Germany
Nycomed Deutschland GmbH
Altflußheim, Germany
Nycomed Deutschland GmbH
Alzenau in Unterfranken, Germany
Nycomed Deutschland GmbH
Angermünde, Germany
...and 707 more locations
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Dyspeptic Symptoms
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Time frame: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Lower Abdominal Pain
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Diarrhoea
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Irritable Bowel Syndrome: Assessment of the Severity of Constipation
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Time frame: 14 days
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Irritable Bowel Syndrome
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Time frame: 14 days
Assessment of the Tolerability of Pantoprazole at Final Visit
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Time frame: 14 days